The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy

DPO multiplex PCR as an alternative to culture and susceptibility testing to detect Helicobacter pylori and its resistance to clarithromycin

(2011) Philippe Lehours et al.   BMC GASTROENTEROLOGY

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

(2011) Peter Malfertheiner et al.   LANCET

Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? authors’ reply

(2010) J. Molina-Infante et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

(2010) M. Romano et al.   GUT

In Response:

(2010) Javier P. Gisbert   JOURNAL OF CLINICAL GASTROENTEROLOGY

Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability

(2009) Jay Luther et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing “Concomitant Therapy” Versus Triple Therapy forHelicobacter pyloriEradication

(2009) Abdallah Said Essa et al.   HELICOBACTER

Evaluation of a New Test, GenoType HelicoDR, for Molecular Detection of Antibiotic Resistance in Helicobacter pylori

(2009) E. Cambau et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis

(2008) Alexander C Ford et al.   WORLD JOURNAL OF GASTROENTEROLOGY